JASCAYD

NERANDOMILAST · Boehringer Ingelheim Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JASCAYD, covering 2025-10-07 to 2026-08-14. Get the full timeline:

Most recent: FDA Approved: JASCAYD — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)